Free Trial
NASDAQ:PXMD

PaxMedica (PXMD) Stock Price, News & Analysis

PaxMedica logo

About PaxMedica Stock (NASDAQ:PXMD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
11,994 shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PaxMedica and its competitors with MarketBeat's FREE daily newsletter.

PXMD Stock News Headlines

PaxMedica, Inc. (PXMD) - Yahoo Finance
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.
PXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024
See More Headlines

PXMD Stock Analysis - Frequently Asked Questions

PaxMedica's stock reverse split on Tuesday, October 31st 2023.The 1-17 reverse split was announced on Monday, October 30th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 30th 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

PaxMedica (PXMD) raised $9 million in an IPO on Friday, August 26th 2022. The company issued 1,600,000 shares at a price of $4.50-$6.50 per share. Craft Capital Management and R.F.Lafferty & Co. served as the underwriters for the IPO.

Shares of PXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PaxMedica investors own include Pfizer (PFE), PayPal (PYPL), Oracle (ORCL), Arista Networks (ANET), Avino Silver & Gold Mines (ASM) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PXMD
CIK
1811623
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.29 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-3,167.89%
Return on Assets
-560.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.38
Quick Ratio
0.38

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.46 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,312,000
Free Float
11,199,000
Market Cap
$1 thousand
Optionable
Not Optionable
Beta
-1.01

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PXMD) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners